TABLE 4.
The top 15 enriched KEGG pathway terms of the methylated DEGs.
ID | Term | Count | p value | Fdr | Enrichment score | Genes |
---|---|---|---|---|---|---|
hsa04062 | Chemokine signaling pathway | 6 | 0.005106388 | 0.52554437 | 2.291886204 | ADCY4//CXCL5//CXCL6//HCK//PF4V1//STAT3 |
hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4 | 0.010010388 | 0.52554437 | 1.999549072 | CXCL5//CXCL6//PF4V1//TNFRSF10D |
hsa04630 | JAK-STAT signaling pathway | 5 | 0.011756369 | 0.52554437 | 1.929726788 | AOX1//LEP//PDGFRB//STAT3//STAT5A |
hsa05416 | Viral myocarditis | 3 | 0.014071423 | 0.52554437 | 1.851661979 | HLA-A//HLA-E//LAMA2 |
hsa04920 | Adipocytokine signaling pathway | 3 | 0.020418909 | 0.52554437 | 1.689967473 | CPT1C//LEP//STAT3 |
hsa01230 | Biosynthesis of amino acids | 3 | 0.025393337 | 0.52554437 | 1.595280232 | PGK1//PRPS2//PYCR1 |
hsa05133 | Pertussis | 3 | 0.026280353 | 0.52554437 | 1.58036881 | CXCL5//CXCL6//SERPING1 |
hsa05169 | Epstein-Barr virus infection | 5 | 0.027237069 | 0.52554437 | 1.564839633 | HDAC1//HLA-A//HLA-E//RUNX3//STAT3 |
hsa05203 | Viral carcinogenesis | 5 | 0.027237069 | 0.52554437 | 1.564839633 | HDAC1//HLA-A//HLA-E//STAT3//STAT5A |
hsa04612 | Antigen processing and presentation | 3 | 0.028103977 | 0.52554437 | 1.551232219 | CD74//HLA-A//HLA-E |
hsa04060 | Cytokine-cytokine receptor interaction | 6 | 0.037473107 | 0.525800484 | 1.426280294 | CXCL5//CXCL6//GDF5//LEP//PF4V1//TNFRSF10D |
hsa05330 | Allograft rejection | 2 | 0.040811779 | 0.525800484 | 1.389214476 | HLA-A//HLA-E |
hsa05323 | Rheumatoid arthritis | 3 | 0.04386683 | 0.525800484 | 1.35786375 | CTSK//CXCL5//CXCL6 |
hsa05332 | Graft-versus-host disease | 2 | 0.046843799 | 0.525800484 | 1.329347889 | HLA-A//HLA-E |
hsa05414 | Dilated cardiomyopathy (DCM) | 3 | 0.04745307 | 0.525800484 | 1.32373569 | ADCY4//EMD//LAMA2 |
KEGG, kyoto encyclopedia of genes and genomes.